Two recipients of gene-edited pig kidneys successfully transition to human organ transplants

STAT News reports that two patients who had previously received gene-edited pig kidneys as a bridge measure have now received human donor organs, marking a milestone in clinical xenotransplantation.

Published · AI-drafted summary based on 1 public source
Illustration for crispr story
Illustrative image — not from the source article.
Share

Two patients who had previously received gene-edited pig kidneys — a xenotransplantation approach intended to address acute organ shortage — have since been transplanted with human donor kidneys, according to reporting by STAT News on 3 September 2026. Both transitions were described as successful, representing an early illustration of how gene-edited pig organs may function as a clinical bridge while patients await human organ availability.

Xenotransplantation using pigs whose genomes have been edited to reduce immunological incompatibility has been an active area of research and early-phase clinical activity for several years. Gene edits applied to donor pigs typically include removal of pig-specific carbohydrate antigens that trigger hyperacute rejection, and in some programmes the addition of human complement-regulatory or immune-modulatory transgenes. The field gained wider attention following a series of high-profile cases beginning in the early 2020s.

The cases reported here are significant because they demonstrate that prior receipt of a gene-edited xenograft did not preclude subsequent successful human organ transplantation — an important practical and immunological question for the field. The full clinical details, including immunosuppression regimens and any sensitisation outcomes, were not available in public reporting at the time of writing; primary clinical data should be sought from peer-reviewed publications as they emerge.

For researchers in transplantation genetics and immunogenetics, this development adds to the growing clinical dataset informing the safety and feasibility of xenotransplantation as a bridge strategy.

Plain-language version

For patients, families, and general readers. Educational only — not medical advice.

Doctors sometimes struggle to find enough human donor kidneys for everyone who needs one. Scientists have been working on an idea: using kidneys from pigs whose genes have been changed (edited) to make them less likely to be rejected by a human body.

Two people who had received one of these gene-edited pig kidneys have now gone on to receive a human kidney transplant, and both transplants went well. This is an early sign that receiving a pig organ first does not prevent someone from later receiving a human organ.

Researchers say this helps answer an important question about how safe and practical this approach might be in future. The science is still at an early stage, and much more study is needed.

This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.

Sources

Read the original reporting — these are the public sources this summary draws from.

  1. Primary source Stat News · 2026-09-03
    STAT+: Recipients of gene-edited pig kidneys successfully receive human organs

Tags

xenotransplantation gene-editing kidney-transplant transplantation-genetics immunogenetics pig-organ
Share

About Genetic Current

Educational summaries of public genetics news

Genetic Current is the news section of Evagene, an academic, research, and educational pedigree-modelling platform. Stories are AI-drafted summaries of items from trusted public sources, written for researchers, clinicians, educators, students, genealogists, and patients with an interest in genetics. Summaries are for educational and research purposes only and are not medical advice.

Join the Evagene Alpha Waiting List